+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmesis International Ltd (BFK) - Financial and Strategic SWOT Analysis Review

  • ID: 4382952
  • SWOT Analysis
  • September 2020
  • Region: Global
  • 34 pages
  • GlobalData
Pharmesis International Ltd (BFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pharmesis International Ltd (Pharmesis) focuses on the research, development production, and commercialization of pharmaceutical products (Western medicine) and traditional Chinese medicines (TCM). It provides formulated products for the treatment of illnesses related to the liver and gall bladder. The company offers TCM formulated products through Longlife brand and Western medicine products through Kinna brand. Pharmesis also offers health supplements. The company has production facilities in the cities of Chengdu and Guilin in the Sichuan Province. It has collaborations with research institutes in China to identify and develop new drugs. Pharmesis sells its products in China through an established sales and marketing network. Pharmesis is headquartered in Chengdu, Sichuan, China.

Pharmesis International Ltd Key Recent Developments

Apr 01, 2020: Pharmesis International: Resumption of operations at Gulin production facility
Feb 21, 2020: Pharmesis International: Resumption of operations at our Chengdu production facility
Feb 06, 2020: Pharmesis International: Temporary closure of our production facilities
Nov 04, 2019: Pharmesis International: Profit guidance for the group’s unaudited financial results for third quarter and nine months ended 30 september 2019profit guidance for the group’s unaudited financial results for third quarter and nine months ended 30 September 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Pharmesis International Ltd - Key Facts
  • Pharmesis International Ltd - Key Employees
  • Pharmesis International Ltd - Key Employee Biographies
  • Pharmesis International Ltd - Major Products and Services
  • Pharmesis International Ltd - History
  • Pharmesis International Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Pharmesis International Ltd - Business Description
  • Business Segment: Distribution
  • Overview
  • Performance
  • Business Segment: TCM Formulated Drugs
  • Overview
  • Performance
  • Business Segment: Western drugs segment
  • Overview
  • Performance
  • R&D Overview
  • Pharmesis International Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharmesis International Ltd - Strengths
  • Pharmesis International Ltd - Weaknesses
  • Pharmesis International Ltd - Opportunities
  • Pharmesis International Ltd - Threats
  • Pharmesis International Ltd - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Recent Developments
  • Apr 01, 2020: Pharmesis International: Resumption of operations at Gulin production facility
  • Feb 21, 2020: Pharmesis International: Resumption of operations at our Chengdu production facility
  • Feb 06, 2020: Pharmesis International: Temporary closure of our production facilities
  • Nov 04, 2019: Pharmesis International: Profit guidance for the group’s unaudited financial results for third quarter and nine months ended 30 september 2019profit guidance for the group’s unaudited financial results for third quarter and nine months ended 30 September 2019
Section 5 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Pharmesis International Ltd, Key Facts
  • Pharmesis International Ltd, Key Employees
  • Pharmesis International Ltd, Key Employee Biographies
  • Pharmesis International Ltd, Major Products and Services
  • Pharmesis International Ltd, History
  • Pharmesis International Ltd, Other Locations
  • Pharmesis International Ltd, Subsidiaries
  • Pharmesis International Ltd, Key Competitors
  • Pharmesis International Ltd, Ratios based on current share price
  • Pharmesis International Ltd, Annual Ratios
  • Pharmesis International Ltd, Annual Ratios (Cont...1)
  • Pharmesis International Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pharmesis International Ltd, Performance Chart (2015 - 2019)
  • Pharmesis International Ltd, Ratio Charts
Note: Product cover images may vary from those shown
  • Suzhou Heng Xiang Import & Export Co Ltd
  • Changsha Huakang Biotechnology Development Co Ltd
  • Beijing Tong Ren Tang Co Ltd
  • Shanghai Sundise Chinese Medicine Technology Development Co Ltd
  • Shijiazhuang Pharma Group Hebei Zhongrun Pharmaceutical Co., Ltd
  • North China Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll